PubMed:12499404 / 1225-1497
Annnotations
sentences
{"project":"sentences","denotations":[{"id":"TextSentencer_T8","span":{"begin":0,"end":131},"obj":"Sentence"},{"id":"TextSentencer_T9","span":{"begin":132,"end":272},"obj":"Sentence"},{"id":"T8","span":{"begin":0,"end":272},"obj":"Sentence"},{"id":"T8","span":{"begin":0,"end":131},"obj":"Sentence"},{"id":"T9","span":{"begin":132,"end":272},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The uptake was three to four times higher than that of the nontreated alpha-GalA and was inhibited by the addition of 5 mM Man-6-P. Incorporated alpha-GalA was targeted to the lysosome, and hydrolyzed ceramide trihexoside accumulated in the Fabry fibroblasts after 5 days."}
GlycoBiology-FMA
{"project":"GlycoBiology-FMA","denotations":[{"id":"_T25","span":{"begin":176,"end":184},"obj":"FMAID:162299"},{"id":"_T26","span":{"begin":176,"end":184},"obj":"FMAID:63836"},{"id":"_T27","span":{"begin":247,"end":258},"obj":"FMAID:63877"},{"id":"_T28","span":{"begin":247,"end":258},"obj":"FMAID:162340"}],"namespaces":[{"prefix":"FMAID","uri":"http://purl.org/sig/ont/fma/fma"}],"text":"The uptake was three to four times higher than that of the nontreated alpha-GalA and was inhibited by the addition of 5 mM Man-6-P. Incorporated alpha-GalA was targeted to the lysosome, and hydrolyzed ceramide trihexoside accumulated in the Fabry fibroblasts after 5 days."}
GlycoBiology-NCBITAXON
{"project":"GlycoBiology-NCBITAXON","denotations":[{"id":"T6","span":{"begin":267,"end":271},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/82391"}],"text":"The uptake was three to four times higher than that of the nontreated alpha-GalA and was inhibited by the addition of 5 mM Man-6-P. Incorporated alpha-GalA was targeted to the lysosome, and hydrolyzed ceramide trihexoside accumulated in the Fabry fibroblasts after 5 days."}
GO-BP
{"project":"GO-BP","denotations":[{"id":"T3","span":{"begin":4,"end":10},"obj":"http://purl.obolibrary.org/obo/GO_0098657"}],"text":"The uptake was three to four times higher than that of the nontreated alpha-GalA and was inhibited by the addition of 5 mM Man-6-P. Incorporated alpha-GalA was targeted to the lysosome, and hydrolyzed ceramide trihexoside accumulated in the Fabry fibroblasts after 5 days."}
GO-CC
{"project":"GO-CC","denotations":[{"id":"T3","span":{"begin":176,"end":184},"obj":"http://purl.obolibrary.org/obo/GO_0005764"}],"text":"The uptake was three to four times higher than that of the nontreated alpha-GalA and was inhibited by the addition of 5 mM Man-6-P. Incorporated alpha-GalA was targeted to the lysosome, and hydrolyzed ceramide trihexoside accumulated in the Fabry fibroblasts after 5 days."}
EDAM-topics
{"project":"EDAM-topics","denotations":[{"id":"T10","span":{"begin":160,"end":168},"obj":"http://edamontology.org/topic_0154"},{"id":"T11","span":{"begin":176,"end":184},"obj":"http://edamontology.org/topic_0616"}],"text":"The uptake was three to four times higher than that of the nontreated alpha-GalA and was inhibited by the addition of 5 mM Man-6-P. Incorporated alpha-GalA was targeted to the lysosome, and hydrolyzed ceramide trihexoside accumulated in the Fabry fibroblasts after 5 days."}
Lectin
{"project":"Lectin","denotations":[{"id":"Lectin_T6","span":{"begin":123,"end":126},"obj":"https://acgg.asia/db/lfdb/LfDB0217"}],"text":"The uptake was three to four times higher than that of the nontreated alpha-GalA and was inhibited by the addition of 5 mM Man-6-P. Incorporated alpha-GalA was targeted to the lysosome, and hydrolyzed ceramide trihexoside accumulated in the Fabry fibroblasts after 5 days."}
GlyTouCan-IUPAC
{"project":"GlyTouCan-IUPAC","denotations":[{"id":"GlycanIUPAC_T16","span":{"begin":76,"end":80},"obj":"\"http://rdf.glycoinfo.org/glycan/G38580BH\""},{"id":"GlycanIUPAC_T17","span":{"begin":151,"end":155},"obj":"\"http://rdf.glycoinfo.org/glycan/G38580BH\""},{"id":"GlycanIUPAC_T24","span":{"begin":76,"end":80},"obj":"\"http://rdf.glycoinfo.org/glycan/G84837AK\""},{"id":"GlycanIUPAC_T25","span":{"begin":151,"end":155},"obj":"\"http://rdf.glycoinfo.org/glycan/G84837AK\""},{"id":"GlycanIUPAC_T32","span":{"begin":76,"end":80},"obj":"\"http://rdf.glycoinfo.org/glycan/G77163MT\""},{"id":"GlycanIUPAC_T33","span":{"begin":151,"end":155},"obj":"\"http://rdf.glycoinfo.org/glycan/G77163MT\""},{"id":"GlycanIUPAC_T40","span":{"begin":76,"end":80},"obj":"\"http://rdf.glycoinfo.org/glycan/G21373RF\""},{"id":"GlycanIUPAC_T41","span":{"begin":151,"end":155},"obj":"\"http://rdf.glycoinfo.org/glycan/G21373RF\""},{"id":"GlycanIUPAC_T48","span":{"begin":76,"end":80},"obj":"\"http://rdf.glycoinfo.org/glycan/G23037RJ\""},{"id":"GlycanIUPAC_T49","span":{"begin":151,"end":155},"obj":"\"http://rdf.glycoinfo.org/glycan/G23037RJ\""},{"id":"GlycanIUPAC_T56","span":{"begin":76,"end":80},"obj":"\"http://rdf.glycoinfo.org/glycan/G42940LY\""},{"id":"GlycanIUPAC_T57","span":{"begin":151,"end":155},"obj":"\"http://rdf.glycoinfo.org/glycan/G42940LY\""},{"id":"GlycanIUPAC_T63","span":{"begin":123,"end":126},"obj":"\"http://rdf.glycoinfo.org/glycan/G19151BJ\""},{"id":"GlycanIUPAC_T69","span":{"begin":123,"end":126},"obj":"\"http://rdf.glycoinfo.org/glycan/G63727IH\""},{"id":"GlycanIUPAC_T75","span":{"begin":123,"end":126},"obj":"\"http://rdf.glycoinfo.org/glycan/G05795KA\""},{"id":"GlycanIUPAC_T81","span":{"begin":123,"end":126},"obj":"\"http://rdf.glycoinfo.org/glycan/G90812SJ\""},{"id":"GlycanIUPAC_T87","span":{"begin":123,"end":126},"obj":"\"http://rdf.glycoinfo.org/glycan/G07124DB\""},{"id":"GlycanIUPAC_T93","span":{"begin":123,"end":126},"obj":"\"http://rdf.glycoinfo.org/glycan/G20567HS\""},{"id":"GlycanIUPAC_T99","span":{"begin":123,"end":126},"obj":"\"http://rdf.glycoinfo.org/glycan/G76159WX\""},{"id":"GlycanIUPAC_T105","span":{"begin":123,"end":126},"obj":"\"http://rdf.glycoinfo.org/glycan/G40623UW\""},{"id":"GlycanIUPAC_T111","span":{"begin":123,"end":126},"obj":"\"http://rdf.glycoinfo.org/glycan/G06447MP\""},{"id":"GlycanIUPAC_T117","span":{"begin":123,"end":126},"obj":"\"http://rdf.glycoinfo.org/glycan/G62764VZ\""},{"id":"GlycanIUPAC_T123","span":{"begin":123,"end":126},"obj":"\"http://rdf.glycoinfo.org/glycan/G21434YY\""},{"id":"GlycanIUPAC_T129","span":{"begin":123,"end":126},"obj":"\"http://rdf.glycoinfo.org/glycan/G34267PK\""},{"id":"GlycanIUPAC_T135","span":{"begin":123,"end":126},"obj":"\"http://rdf.glycoinfo.org/glycan/G30235PC\""},{"id":"GlycanIUPAC_T141","span":{"begin":123,"end":126},"obj":"\"http://rdf.glycoinfo.org/glycan/G34820UC\""},{"id":"GlycanIUPAC_T147","span":{"begin":123,"end":126},"obj":"\"http://rdf.glycoinfo.org/glycan/G95531HX\""},{"id":"GlycanIUPAC_T153","span":{"begin":123,"end":126},"obj":"\"http://rdf.glycoinfo.org/glycan/G74672YG\""},{"id":"GlycanIUPAC_T159","span":{"begin":123,"end":126},"obj":"\"http://rdf.glycoinfo.org/glycan/G54440FW\""},{"id":"GlycanIUPAC_T165","span":{"begin":123,"end":126},"obj":"\"http://rdf.glycoinfo.org/glycan/G69182II\""},{"id":"GlycanIUPAC_T171","span":{"begin":123,"end":126},"obj":"\"http://rdf.glycoinfo.org/glycan/G68961XX\""},{"id":"GlycanIUPAC_T177","span":{"begin":123,"end":126},"obj":"\"http://rdf.glycoinfo.org/glycan/G11710CQ\""},{"id":"GlycanIUPAC_T183","span":{"begin":123,"end":126},"obj":"\"http://rdf.glycoinfo.org/glycan/G70765DS\""},{"id":"GlycanIUPAC_T189","span":{"begin":123,"end":126},"obj":"\"http://rdf.glycoinfo.org/glycan/G51661YR\""},{"id":"GlycanIUPAC_T195","span":{"begin":123,"end":126},"obj":"\"http://rdf.glycoinfo.org/glycan/G18477VG\""},{"id":"GlycanIUPAC_T201","span":{"begin":123,"end":126},"obj":"\"http://rdf.glycoinfo.org/glycan/G12337MH\""},{"id":"GlycanIUPAC_T207","span":{"begin":123,"end":126},"obj":"\"http://rdf.glycoinfo.org/glycan/G40783MY\""},{"id":"GlycanIUPAC_T213","span":{"begin":123,"end":126},"obj":"\"http://rdf.glycoinfo.org/glycan/G72867LN\""},{"id":"GlycanIUPAC_T219","span":{"begin":123,"end":126},"obj":"\"http://rdf.glycoinfo.org/glycan/G79061OT\""},{"id":"GlycanIUPAC_T225","span":{"begin":123,"end":126},"obj":"\"http://rdf.glycoinfo.org/glycan/G45970UX\""},{"id":"GlycanIUPAC_T231","span":{"begin":123,"end":126},"obj":"\"http://rdf.glycoinfo.org/glycan/G93661NW\""},{"id":"GlycanIUPAC_T237","span":{"begin":123,"end":126},"obj":"\"http://rdf.glycoinfo.org/glycan/G04988XL\""},{"id":"GlycanIUPAC_T243","span":{"begin":123,"end":126},"obj":"\"http://rdf.glycoinfo.org/glycan/G85800UH\""},{"id":"GlycanIUPAC_T249","span":{"begin":123,"end":126},"obj":"\"http://rdf.glycoinfo.org/glycan/G96338GZ\""},{"id":"GlycanIUPAC_T255","span":{"begin":123,"end":126},"obj":"\"http://rdf.glycoinfo.org/glycan/G96296PU\""},{"id":"GlycanIUPAC_T261","span":{"begin":123,"end":126},"obj":"\"http://rdf.glycoinfo.org/glycan/G59124WZ\""},{"id":"GlycanIUPAC_T267","span":{"begin":123,"end":126},"obj":"\"http://rdf.glycoinfo.org/glycan/G57275GR\""},{"id":"GlycanIUPAC_T273","span":{"begin":123,"end":126},"obj":"\"http://rdf.glycoinfo.org/glycan/G46105MZ\""},{"id":"GlycanIUPAC_T279","span":{"begin":123,"end":126},"obj":"\"http://rdf.glycoinfo.org/glycan/G76001GO\""},{"id":"GlycanIUPAC_T285","span":{"begin":123,"end":126},"obj":"\"http://rdf.glycoinfo.org/glycan/G89599ML\""},{"id":"GlycanIUPAC_T291","span":{"begin":123,"end":126},"obj":"\"http://rdf.glycoinfo.org/glycan/G85872BD\""},{"id":"GlycanIUPAC_T297","span":{"begin":123,"end":126},"obj":"\"http://rdf.glycoinfo.org/glycan/G69460YK\""},{"id":"GlycanIUPAC_T303","span":{"begin":123,"end":126},"obj":"\"http://rdf.glycoinfo.org/glycan/G25240JV\""},{"id":"GlycanIUPAC_T309","span":{"begin":123,"end":126},"obj":"\"http://rdf.glycoinfo.org/glycan/G80489OS\""},{"id":"GlycanIUPAC_T315","span":{"begin":123,"end":126},"obj":"\"http://rdf.glycoinfo.org/glycan/G35726XK\""},{"id":"GlycanIUPAC_T321","span":{"begin":123,"end":126},"obj":"\"http://rdf.glycoinfo.org/glycan/G11002JA\""},{"id":"GlycanIUPAC_T327","span":{"begin":123,"end":126},"obj":"\"http://rdf.glycoinfo.org/glycan/G85388FO\""},{"id":"GlycanIUPAC_T333","span":{"begin":123,"end":126},"obj":"\"http://rdf.glycoinfo.org/glycan/G20221JL\""},{"id":"GlycanIUPAC_T339","span":{"begin":123,"end":126},"obj":"\"http://rdf.glycoinfo.org/glycan/G39026SP\""},{"id":"GlycanIUPAC_T345","span":{"begin":123,"end":126},"obj":"\"http://rdf.glycoinfo.org/glycan/G66979UZ\""},{"id":"GlycanIUPAC_T351","span":{"begin":123,"end":126},"obj":"\"http://rdf.glycoinfo.org/glycan/G68566EA\""},{"id":"GlycanIUPAC_T357","span":{"begin":123,"end":126},"obj":"\"http://rdf.glycoinfo.org/glycan/G20255ZD\""},{"id":"GlycanIUPAC_T363","span":{"begin":123,"end":126},"obj":"\"http://rdf.glycoinfo.org/glycan/G68860MF\""},{"id":"GlycanIUPAC_T369","span":{"begin":123,"end":126},"obj":"\"http://rdf.glycoinfo.org/glycan/G50413KD\""}],"text":"The uptake was three to four times higher than that of the nontreated alpha-GalA and was inhibited by the addition of 5 mM Man-6-P. Incorporated alpha-GalA was targeted to the lysosome, and hydrolyzed ceramide trihexoside accumulated in the Fabry fibroblasts after 5 days."}
Anatomy-UBERON
{"project":"Anatomy-UBERON","denotations":[{"id":"T3","span":{"begin":176,"end":184},"obj":"Body_part"},{"id":"T4","span":{"begin":247,"end":258},"obj":"Body_part"}],"attributes":[{"id":"A3","pred":"uberon_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/GO_0005764"},{"id":"A4","pred":"uberon_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/CL_0000057"}],"text":"The uptake was three to four times higher than that of the nontreated alpha-GalA and was inhibited by the addition of 5 mM Man-6-P. Incorporated alpha-GalA was targeted to the lysosome, and hydrolyzed ceramide trihexoside accumulated in the Fabry fibroblasts after 5 days."}
CL-cell
{"project":"CL-cell","denotations":[{"id":"T2","span":{"begin":247,"end":258},"obj":"Cell"}],"attributes":[{"id":"A2","pred":"cl_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/CL:0000057"}],"text":"The uptake was three to four times higher than that of the nontreated alpha-GalA and was inhibited by the addition of 5 mM Man-6-P. Incorporated alpha-GalA was targeted to the lysosome, and hydrolyzed ceramide trihexoside accumulated in the Fabry fibroblasts after 5 days."}